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Severe carotid stenosis patients in the North American Symptomatic Carotid Endarterectomy Trial (NASCET) were
shown to have a high risk of stroke and significant benefit from carotid endarterectomy. More than 20 years after
the 1991 NASCET results for severe stenosis, there is a common claim to use the NASCET method to determine %
carotid stenosis, but without following the details necessary to properly identify the group most benefitting from
carotid endarterectomy. NASCET interpreted for loss of diameter of the cervical ICA, near occlusion, and didn’t
calculate % stenosis if present as it is fallacious. NASCET measured the distal ICA for well beyond the tapering ICA
bulb where the ICA walls are parallel.
The pitfalls of stenosis quantification and differences between methods are problems of the ratio’s denominator,
and may potentially be resolved by the use of absolute measurements for stenosis on CTA or MRA. Furthermore,
trials evaluating vessel wall components including intraplaque hemorrhage such as CAIN may add to or replace
degree of stenosis for the prediction of cerebrovascular outcomes.Summary of NASCET’s design, early stop, and
surprisingly strong results
The North American Symptomatic Carotid Endarterec-
tomy Trial (NASCET) was designed to verify the super-
iority of carotid surgical revascularization to prevent
stroke or death compared to best available medical man-
agement [1]. The severe stenosis arm of NASCET was
stopped early by the National Institutes of Health (NIH)
in February 1991, well ahead of the planned time [2].
This happened from documentation of stroke risk much
worse than known before, in addition to surgical efficacy
yielding significant surgical benefit for stroke prevention.
NASCET’s method of quantification (Figure 1) of carotid
stenosis [2-4] was credited with defining the group of
very high-risk cases in the medical group that had not
previously been identified. The stenosis categorization
method was also considered as a main factor for the tri-
al’s early success to find surgical benefit for the defined
severe stenosis group. Yet perhaps NASCET’s “severe
stenosis” could have been called “very severe”, since
many operators have trouble reconciling the fact that* Correspondence: ajfox@uwo.ca
1Department of Medical Imaging, Faculty of Medicine, University of Toronto,
Toronto, Canada
2Neuroradiology Division, Department of Medical Imaging, Sunnybrook
Health Sciences Centre, 2075 Bayview Avenue, Toronto M4N 3M5, Canada
© 2015 Fox and Singh; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.calculation of 70% or more stenosis appears worse than
what many would call severe from a mere glance.
Different Methods of Stenosis Measurement and
Reconciliation of Stenosis with ECST
NASCET paralleled the European Carotid Surgery Trial
(ECST), also stopped for its severe group outcomes, al-
though with notably less strength of outcome data than
NASCET’s [5]. Both studies identified the severe group
as 70% stenosis or more, yet it was realized that their
methods of quantifying % stenosis differed, making the
studied groups quite different from each other as well as
the strength of the surgical results. NASCET isolated a
more severe stenotic group with greater stroke risk and
greater surgical benefit. For example, the 70% stenosis
cut-off for ECST corresponded to about 40% stenosis for
NASCET, while NASCET’s 70% stenosis was about 85%
ECST [6]. Given that the NASCET moderate stenosis
group, measured as 50-69% stenosis, hardly had slight
benefit of surgery [7], it is easy to understand why
ECST’s severe group showed a muted benefit of surgery
compared to NASCET, since it contained both NAS-
CET’s severe and moderate groups [3,7].
There had always been different ways to assign % ca-
rotid stenosis [1,3]. The blatant differences between
NASCET and ECST methods and results were strikingal. This is an Open Access article distributed under the terms of the Creative
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Figure 1 Shows a conceptualized drawing of the calculation of
% stenosis = (1 – N/D)100, with N as the narrowest observed
diameter and D as the diameter of the “normal” internal
carotid diameter well beyond the bulb where the walls are
parallel. Reproduced with permission from Radiology [3].
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each has its own logic [3,7,8]. NASCET chose a method
that effectively quantifies stenosis based on the luminal re-
duction compared to the internal carotid artery (ICA) dis-
tal outflow (Figure 1). ECST’s method measures from
luminal reduction of the stenosis and compares it to the
unseen ICA bulb width on standard angiography (the
stenotic atheroma covers it). This ECST % is derived from
a denominator of up to twice the diameter of the distal
ICA, with ICA bulb being the largest part of the artery.
NASCET’s method is most commonly used today as it
relates to the higher stroke risk group and stronger sur-
gical benefit found in NASCET. In a sense, all methods
are arbitrary and anyone can use what they prefer, how-
ever, the outcome results of both NASCET and ECST
are very specific to the respective methods used. It
seems incorrect to use NASCET’s clinical results unless
used with NASCET’s stenosis method. Indeed, analysing
the results together from both NASCET and ECST [8]
for combined analysis, NASCET’s method was used for
all cases.
In effect, NASCET defined its severe group in a way not
previously highlighted, and it could be said that NASCET’s
“severe” group is really “very severe” , while its moderate
group could give the impression of very prominentstenosis if identified just by the eye, without adhering to
measurements and calculation of % stenosis [3,4].
Role of stenosis measurement in NASCET’s success
The early NASCET stop by NIH for severe stenosis in
1991 was based on NASCET’s stenosis degree for 70%
or more with the 2-year stroke risk being over 20% of
cases for 70-79% stenosis, 30% for cases for 80-89% sten-
osis, and 40% of cases for 90-99% of cases [2,3]. The sur-
gical group showed 2-year stroke risk in the 10% range
for all severe stenosis degrees, including peri-operative
risks, yielding a two-year stroke prevention benefit of
14%, 18%, and 26% of cases for each of the three deciles
of stenosis degree [2].
While the NASCET group with 50-69% stenosis showed
an overall modest benefit to prevent stroke [7], this was
negative for some studied clinical groups, while there was
little latitude for surgical complications that could easily
erase the muted benefit for all cases in this study group.
The 70% stenosis threshold remained a strong criterion
for surgery.
Both the incidences of stroke risk and surgical success
to prevent stroke were substantially greater than had
been predicted in the planning stages for the trial. In ef-
fect, NASCET through its % stenosis method (Figure 1)
was original to study this group of very severe stenosis
that greatly benefited from surgical endarterectomy.
Pitfalls of NASCET measurement
1) Lack of compliance with NASCET’s stenosis Methods:
Perhaps the biggest pitfall of using the NASCET
method for % stenosis is lack of compliance [4] to the
specific details of how NASCET used its method. A
stenosis of NASCET moderate degree could naively be
called “severe” to the eye if not measured. Indeed, the
observations of NASCET’s chief neuroradiological inves-
tigator (AJF) is that to satisfy the diameter ratio criteria
of NASCET, the residual stenosed lumen needs to be re-
duced to little more than a thread; if the reduced lumen
has substance that is clearly seen, it is unlikely to fulfil
measurement criteria for 70% or more.
2) Lack of Assessment for Near Occlusion:
The nearly complete collapse of ICA lumen beyond a
very severe stenosis is (Figure 2) known by with a variety
of names, called near occlusion in NASCET [1,3,9-12].
Less well identified is a lesser physiological loss of diam-
eter of ICA beyond severe stenosis (Figures 3, 4) that
can be considered “normal-looking” but otherwise shows
partial collapse [11,12]. Both categories are called near
occlusion in NASCET [1,3,9-12], representing complete
Figure 2 Shows a conceptualized drawing of “near occlusion”
as a collapsed lumen beyond very severe stenosis with flow
reduction associated with presumed physiological loss of
diameter of the distal ICA. NASCET recognized that any % stenosis
calculation from such a reduced distal ICA lumen was flawed.
Figure 2 is a reproduced part of a figure in Stroke (1). “Promotional
and commercial use of the material in print, digital or mobile device
format is prohibited without the permission from the publisher
Lippincott Williams & Wilkins. Please contact
journalpermissions@lww.com for further information”.
Figure 3 Shows less profound near occlusion with an
angiogram of the “normal-appearing” internal carotid well
beyond a prominent ICA bulb stenosis, with its diameter (large
arrow) narrower that the external carotid diameter nearby,
implying partial collapse of the distal ICA. The ICA diameter
should be substantially larger than ECA diameter. Picture reproduced
with permission from AJNR [11].
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and calculated for % stenosis because the distal ICA
diameter is too small and not truly normal. NASCET
understood that no measurements could be correctly
taken for near occlusion [1,3,9-12] because to do so
would be fallacious. Yet many still do not recognize par-
tial collapse as near occlusion and go ahead to falla-
ciously calculate % stenosis. As such the yielded % can
be substantially less than severe stenosis [4]. To avert
this lack of compliance, NASCET suggested that before
any stenosis be measured it should be first interpreted
for presence or not of the subtle near occlusion [1,3,4].
By ignoring these subtler near occlusion cases and
blindly applying measurements, the partly collapsed de-
nominator for % calculation will artificially reduce the %
stenosis [3,4], with some cases of severe stenosis falla-
ciously calculated as 60% or even less. There are even
published reports suggesting that NASCET’s method can
underestimate stenosis degree; these, however, are really
reports by operators and authors who did not payattention to or comply with NASCET’s instructions to in-
terpret for near occlusion before applying any measure-
ments. This is needed to avoid false measurements
[1,3,4,11]. Claiming to use NASCET’s approach but failing
to identify near occlusions could result in management
decisions that differ from NASCET clinical outcome
categories.
3) Denominator Measurement for % Stenosis:
NASCET chose a denominator to calculate % stenosis
using the distal ICA diameter well beyond the bulb
Figure 4 Shows a reformatted image from a CTA “normal-
appearing” internal carotid well beyond a prominent ICA bulb
stenosis, with its diameter (large arrow) narrower that the
external carotid diameter nearby, implying partial collapse of
the distal ICA. ICA diameter should be substantially larger than ECA
diameter. Picture reproduced with permission from AJNR [12].
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tomical aberration [1,3] where the artery becomes much
larger than its inflow parent CCA, and becomes much
smaller than its outflow ICA. The transition from wide
bulb to narrower outflow ICA is a gradual tapering ves-
sel. To choose a changing diameter structure for % cal-
culation purposes seems both illogical and incorrect [4]
when one can choose a parallel part of the artery, where
the walls are parallel. Measuring ICA where it is larger
than the distal ICA where walls are parallel falsely in-
creases the calculated % stenosis [4]. Claiming to use
NASCET’s approach but failing to measure the distal
normal well beyond the bulb where the walls are parallel
could result in management decisions that differ from
NASCET clinical outcome categories.
Other Methods and New Imaging Methods with
Capability for Measurement
1) Millimetre (mm) Diameter Measurements:
NASCET outcome results [2,7] are considered a “bible”
of stroke prevention management for symptomatic pa-
tients with carotid stenosis. Misuse of NASCET % sten-
osis calculations [4] exists. There is reluctance by many
to abandon NASCET % stenosis because NASCET out-
comes derived from % stenosis. In the days of standard
angiography, % calculation made sense: old film angiog-
raphy had uncertainty of magnification factors for real
measurements, while digital subtraction angiography
(DSA) was basically expressed in pixels and not real mm.
The pitfalls of NASCET % stenosis arise mainly from the
denominator; yet the numerator essentially expresses the
lumen [3]. Now in an era when real mm are part of CTA
(Figure 5) and MRA, it seems appropriate and logical to
eliminate the problem denominator and consider the
quantification of stenosis based on mm diameter of the
residual lumen. That has been done in a series of exper-
iments using a CTA stenosis database [12-16] and com-
paring mm stenosis with other derived stenosis
methods. The CTA method shown in Figure 5 [13] uses
measurements from thin axial source images which
have highest spatial resolution, guided by reformats in
other directions. Today we get accurate mm diameters;
why persist with a % method that was useful when DSA
did could not give accurate mm when now CTA gives
mm, especially since problems with compliance with
the NASCET approach are due to variable and incon-
sistent ways to determine the denominator for % ratio?
The CTA approach also includes improvements to
view a stenosis compared to angiography as was used in
NASCET. NASCET used the narrowest diameter from
available angiographic views, which were often quite
limited, while CTA now allows a full cross-sectional look
Figure 5 shows axial (A) and sagittal (B) reformatting of a right
ICA bulb stenosis with large plaque ulcer/uplifted plaque. The
larger solid arrow shows the reduced ICA lumen at the stenosis,
readily measured by CT caliper tool, more accurate from the axial
source image. The dashed arrow indicates the ulcerated plaque and
small arrow the ECA. Picture reproduced with permission from AJNR
[13]. The thin axial source images are used for measurement as they
have the highest spatial resolution.
Figure 6 shows multiplanar images (coronal (A), axial (B) and sagittal
(arrowheads). IPH is indicated by the high signal intensity of methemoglo
reproduced with permission from the International Journal of Cardiovascul
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[13]. CTA shows soft tissue in addition to lumen, so that
outside artery walls can be seen [15], not visible with
standard or subtraction angiography. Plaque ulceration
can potentially be seen more often than just by chance
getting the right angle to show it. Yet despite these ad-
vances and logical explanations and despite the publica-
tion of the Bartlett work on CTA mm stenosis [13-16]
there is continued reluctance to abandon % stenosis.
2) Other Methods for % Stenosis Calculations:
There remain multiple other ways to express % stenosis,
using ratios of carotid artery and different basic measure-
ments [3,5,6]. They remain alternatives, each with their
own logic of approach, their own following, and all pro-
duce % stenosis numbers different from NASCET for the
same stenosis [3,6]. All methods are arbitrary, including
NASCET’s method. The justification to use NASCET’s
method comes from the NASCET outcome results and
their statistical strength. Indeed, while ECST initially used
a different method, for meta-analysis it converted to NAS-
CET’s approach [6,8] recognizing that NASCET outcome
results of stroke risk and surgical benefit was substantially
stronger identifying cases with the NASCET method [2]
than results with ECST [5].(C) demonstrating MR-depicted intraplaque hemorrhage (IPH)
bin on this T1-weighted gradient echo MRI technique. Figure
ar Imaging [26].
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press % stenosis, derive different numbers from NAS-
CET for stenosis degree, and use them as long as they
do not use their % stenosis matched with NASCET out-
come results, not scientifically or clinically correct [3,4].
Yet all % stenosis methods utilize the narrowest mea-
sured diameter of ICA bulb stenosis. There would be no
remaining dispute of which denominator to use for cal-
culation if all would concentrate on the mm stenosis
and not choose a denominator [13-16].
3) Potential Acceptance of mm Stenosis:
It seems that NASCET’s excellent outcome results
command greater popular credibility than the logical
and anatomical reasons for switching to mm stenosis.
That suggests that a similarly credible result of a new
randomized trial for carotid stenosis management may
be the only way to establish mm stenosis as a new stand-
ard, as long as the new trial includes CTA (or MRA al-
though the measurement resolution of CTA is higher
than commonly used MRA), will derive both mm and
NASCET % stenosis, and will relate stenosis to out-
comes. It is not expected that NASCET will be redone.
A related study is the new CREST, which will include
CTA for many of its cases. The CREST trialists will have
an opportunity to show outcomes along with secondary
analyses between % stenosis, mm stenosis, and Doppler
velocities.
4) Ultrasound Depiction of % Stenosis:
Doppler/duplex ultrasound measures velocity to deter-
mine stenosis, not anatomical mm measurements. There
is technical variability of technologist ability to find a
maximal velocity. Doppler measures velocity, not ana-
tomical diameter. Yet, the clinical trials that determined
management for carotid stenosis are studied as % sten-
osis, so there are common attempts to express ultra-
sound results as % stenosis, even though there is no
linear conversion. Modern ultrasound machines include
software tables to convert velocity to % stenosis, with
the derivation of the original tables hard to verify. The
real measurements of Doppler are velocities. Yet Dopp-
lers are often reported as % stenosis very distant from
original angiographic comparisons for those tables, and
with uncertainty of the relationship to the NASCET
method [17].
5) Vessel Wall Content—“Unstable Plaque” :
The concept of the instability of plaque content as be-
ing an important risk factor for carotid stenosis is under-
going study. Intra-plaque haemorrhage (IPH) has longbeen presumed as such a risk factor, though to identify
it was previously difficult. IPH seems to be more preva-
lent in higher grades of carotid stenosis. However,
groups studying IPH appear to focus more on demon-
strating that IPH is a risk factor for plaque progression
defined by vessel wall or plaque volumes [18,19].
Now the ability to image plaque hematoma in the
methemoglobin phase [20] has brought in a new era
(Figure 6) [21]. IPH may further risk stratify within sten-
osis degree groups. IPH has been shown to predict cere-
brovascular outcomes within various specific stenosis
groups [22-25]. IPH, in conjunction with stenosis, may
provide precise cerebrovascular risk stratification. Larger
and/or more systematic trials are now underway that
should be able to shed light including CAIN [26]. CAIN
is a multi-centre, pan-national serial imaging trial of the
carotids and brain that includes investigation of clinical
and imaging cerebrovascular outcomes [26].
Conclusions
NASCET outcome results for symptomatic carotid sten-
osis are most accepted to determine surgical or interven-
tional management, yet those results are tied to a
particular “severe” way to determine % stenosis degree
[2,7,8]. The so-called NASCET approach to carotid sten-
osis quantification seems to have less than optimal com-
pliance [4], and it is possible that many patients may be
sent to surgical treatment based on NASCET results, yet
for which they do not have the indications, because of
lack of compliance of % stenosis calculations [4]. Mm
stenosis methods [13] have been suggested as replace-
ments especially because they don’t have the pitfalls of
the denominator for ratio calculation. While this is lo-
gical and incorporates the mm calibrations inherent in
cross-sectional imaging, it may need a new clinical out-
come treatment study that uses mm stenosis in order to
change user preference of mm over % stenosis. New
studies may also find that plaque imaging is an import-
ant predictor of stroke from carotid stenosis [18-26],
perhaps even as or more important than stenosis degree.
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